A study published in this issue demonstrates that in ACS cases, in-hospital mortality is correlated with a multitude of factors, including age, gender, troponin levels, necessity of intra-aortic balloon pump insertion or cardiogenic shock at presentation, multivascular disease, out of hospital resuscitation and the presence of impaired renal function, or comorbidities such as arterial hypertension and diabetes [6] . Interestingly, this study shows that older patients require a longer duration of stay in the intensive care unit as compared with younger patients (73.0 ± 8.5 vs 64.4 ± 11.2, p = 0.007), demonstrating that age is correlated not only with mortality, but also with the risk of complications in ACS.
these cases the networks did not show a similar efficacy as in STEMI cases, as they are mainly dedicated to early diagnosis and prompt intervention of STEMI cases, fact that leaves NSTEMI and UA cases somehow neglected.
Different factors have been proved to be associated with in-hospital or long-term mortality in ACS. Gender and age are major factors that can influence mortality, recent studies demonstrating that mortality is significantly higher in women under the age of 60, while in women older than 60 the existing comorbidities have a significant impact on the outcome of revascularization in the long term [2] .
Comorbidities are also strong predictors of death after PCI. Renal failure proved to be strongly associated with a higher risk of death following PCI in acute cases, in a significantly higher extent than in stable coronary artery disease. A recent study demonstrated a double relative risk associated with renal failure in STEMI cases (odds ratio 5.3) as compared with ACS cases (odds ratio 2.1), and with stable coronary artery disease (odds ratio 2.3) [3] .
Heart failure and cardiogenic shock at presentation have also been proved to be associated with a significantly higher death rate, in both STEMI and NSTEMI cases. At the same time, heart failure is a strong predictor of acute kidney failure in patients with STEMI undergoing primary PCI [4] . Other studies demonstrated the impact of multivessel disease on the outcome of the revascularization procedure, being generally accepted that the presence of a multivessel disease has a negative impact on the survival of ACS patients [5] .
A study published in this issue demonstrates that in ACS cases, in-hospital mortality is correlated with a multitude of factors, including age, gender, troponin levels, necessity of intra-aortic balloon pump insertion or cardiogenic shock at presentation, multivascular disease, out of hospital resuscitation and the presence of impaired renal function, or comorbidities such as arterial hypertension and diabetes [6] . Interestingly, this study shows that older patients require a longer duration of stay in the in- However, the main issue raised by this study is how to obtain a more significant reduction in mortality in these cases. Primary percutaneous intervention in STEMI is associated with a mortality as low as 3-5% in experienced centers and this should represent the goal for all ACS cases, including NSTEMI and UA. All the efforts should be made for reaching this goal and eventually for improving furthermore the results of revascularization [7] . A superior network organization, in order to ensure a superior usage of the existing STEMI networks in NSTEMI or UA cases, can represent a major target for intervention. This would lead to a more rapid intervention, before severe complications (such as cardiogenic shock) occur, thus preventing the complications associated with cardiogenic shock and leading to a significant reduction in mortality.
